secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001493152-25-012562
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics appoints Natasha Giordano to board of directors effective Sept 1, 2025
--------------------------------------------------------------------------------

- Natasha Giordano appointed to Oragenics Board effective September 1, 2025.
- Ms. Giordano brings experience from PLx Pharma (CEO), Matinas BioPharma board, and HCA.
- She will receive annual base director fee of $45,000, pro-rated, and $3,750/month for Sept-Dec 2025.
- She has agreed to stand for re-election at next annual meeting of shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315225012562/0001493152-25-012562-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315225012562/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-012562

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer